“Bioneb has the potential to change the future of medicine, others can only dream of “
Nick Havercroft – CEO & Founder Bioneb

About Bioneb Limited

Bioneb has filed in the UK, USA, EU and WIPO in excess of 50 technology patents pending and has world wide exclusive rights on 28 patents approved . Bioneb has also filed many patent pending liquid formulations for over 130 FDA approved drugs including Humira®, Antibiotics, Insulin, Epinephrine, Imitrex®, Exubera, Anticholinergics, Anti-inflammatories, Hormones, Appetite suppressant, Dopamine agonist, Nicotine, Sildenafil, Sumatriptan, Vaccines, Diazepam, Antiemetics, Stimulants opioids, Suboxone®, Diphenhydramine, Morphine, Corticosteroids, Antiemetics, Buprenorphine Tadalafil. Patents have also been filed for bio-logic and bio-similar, insulin formulations, registered, viral formulations, natural medications, vitamin formulations, weight loss formulations and recreational hypertonic saline medical formulations.

Bioneb Limited, a corporation incorporated under the Laws of England and Wales located with its registered office at 78-80 St John Street, London, EC1M 4JA, United Kingdom.

Bioneb strives to be a leader in the pulmonary delivery of medical formulations.


Ultrasonic Vibrating Micron Micro Mesh Technology

Our team

Bioneb Limited Trademarks, Patents and Approvals